SoftBank's Masayoshi Son calls missed Anthropic investment a 'mistake' on eve of Nasdaq IPO
Key Takeaways
- •Masayoshi Son publicly described missing an early investment opportunity in Anthropic as one of his mistakes, one day before the company's Nasdaq debut under the ticker ANT.
- •SoftBank has committed up to $64.6 billion for roughly a 13% stake in OpenAI through Vision Fund 2, while OpenAI's IPO has been pushed back to 2027.
- •Anthropic priced its IPO at $70 to $78 per share, valuing the company at up to roughly $1.4 trillion, after booking $17 billion in third-quarter revenue, up from $1.4 billion a year earlier.
- •Jane Street paid $1.34 billion for Anthropic shares sold through the FTX bankruptcy estate, a position expected to exceed $35 billion once the stock lists.
- •OpenAI lowered its latest funding target to $20 billion from $30 billion and trimmed its expected valuation to $1.25 trillion, according to sources cited by the Financial Times.

SoftBank Group chief executive Masayoshi Son said missing the chance to invest in Anthropic at an earlier stage ranks among his investment "mistakes," remarks made on Wednesday, one day before the maker of the Claude chatbot debuts on the Nasdaq following its November 19 initial public offering.
Son, whose SoftBank has instead placed a heavy bet on OpenAI, admitted that having no stake in the AI lab hitting the market this week stands in contrast with a commitment that has yet to yield a return: OpenAI has pushed its own IPO into 2027, delaying any cashout for Son and SoftBank on their investment.
Son's all-in OpenAI strategy
Speaking at Nikkei's "Dialogues on the Future" conference in Tokyo, Son discussed his firm's all-in investment strategy in Sam Altman's OpenAI, a bet it made while skipping Dario Amodei's Anthropic entirely. Son acknowledged how difficult it is to decide which AI developer to back in the race.
His comments came as the OpenAI wagon SoftBank jumped on continues to delay its IPO, while Anthropic — the company SoftBank has no stake in — is due to go public on Thursday under the ticker ANT on the Nasdaq.
Despite the apparent lag, the SoftBank founder has not cooled on OpenAI, telling the forum that he measures success by how his firm's investments create the future rather than by making money.
As of this report, SoftBank has committed up to $64.6 billion to OpenAI for a cumulative stake of roughly 13%, held through Vision Fund 2, SoftBank's technology-focused investment vehicle. The final $10 billion tranche of a $30 billion follow-on investment in OpenAI was completed on October 1. That level of concentration ties SoftBank's paper fortunes to a private company whose listing is not expected until 2027, while the lab it passed on goes public within days — a rare public spotlight on the winner-picking risk Son himself acknowledged.
Who missed out on Anthropic
Son joins a list of publicly tracked big-name investors who will hold no stake in Anthropic when it debuts on the Nasdaq — either by completely passing up early investment rounds, walking away, or losing their stakes before the IPO.
Sam Bankman-Fried lands in the last category. The disgraced FTX founder, currently serving a 25-year sentence at the FCI Terminal Island low-security federal prison in San Pedro, Los Angeles, held a 13.5% stake in Anthropic through a $500 million investment made in late 2021. The FTX bankruptcy estate sold that position for $1.3 billion in 2024 in a flash sale to repay customers, after the exchange collapsed in November 2022 with an $8 billion hole in customer accounts.
Former FTX executives Caroline Ellison and Nishad Singh also forfeited their stakes to the US government. Those holdings netted $627 million when sold, and the proceeds were directed back to the FTX estate.
The other parties in those Anthropic stake sales are due for large paydays. Jane Street, the New York-based trading firm and one of the buyers, spent $1.34 billion on FTX-linked Anthropic shares that will be worth more than $35 billion once the stock lists.
OpenAI's round shrinks as Anthropic races to list
The IPO timing lag is not the only point of contrast between the two AI companies. Anthropic priced its offering in a range of $70 to $78 a share, valuing the Claude maker at up to roughly $1.4 trillion, Fortune reported. The company booked $17 billion in revenue in the third quarter alone, up from $1.4 billion a year earlier — figures that will give public-market investors their first direct read on the economics of a standalone frontier AI lab, since its leading rivals, including OpenAI, remain private.
OpenAI, meanwhile, has pulled back. Sources told the Financial Times that OpenAI cut its latest funding target to $20 billion from $30 billion and trimmed its expected valuation to $1.25 trillion from $1.4 trillion.
It is not the first time Son has publicly labeled a bet a mistake. After SoftBank's WeWork wager soured in 2019, he said his investment judgment had been "really bad" and that he regretted it "in many ways." WeWork never completed its planned IPO.
The OpenAI commitment has already cost SoftBank on paper. Cryptopolitan reported in late 2025 that the company shed more than $100 billion in market value after selling out of Nvidia to concentrate on OpenAI, as traders began treating SoftBank stock as a proxy for Sam Altman's firm. With ANT set to begin trading on Thursday, the debut will hand investors the first public price for a company Son declined to back — a live reference point against which OpenAI's private valuation and its 2027 listing timeline will now be measured.